Testing Natural and Synthetic Compounds for Fighting Bacteria in Diabetic Ulcers

Greg Howard
4th August, 2024

Testing Natural and Synthetic Compounds for Fighting Bacteria in Diabetic Ulcers

Image Source: Natural Science News, 2024

Key Findings

  • Researchers at Islamic Azad University found that chitosan, ZnO, and ZnO-U. diocia nanoparticles are effective against S. aureus in diabetic ulcers
  • The nanoparticles showed strong antimicrobial activity at very low concentrations, with MIC and MBC values of 0.128 g/mL and 0.178 g/mL, respectively
  • Treatment with these nanoparticles significantly reduced the expression of virulence genes lukED and RNAIII in S. aureus, decreasing the bacteria's ability to cause disease
Diabetic foot infections (DFIs) are a severe complication of diabetes, often leading to increased morbidity, mortality, and a significant reduction in quality of life. The primary culprit behind these infections is Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA) strains, which are notoriously difficult to treat due to their resistance to multiple antibiotics[2][3]. Addressing this problem requires innovative approaches beyond conventional antimicrobial therapies. A recent study conducted by researchers at the Islamic Azad University, Falavarjan Branch, explored the potential of nanotechnology to combat these stubborn infections. The study focused on synthesizing chitosan, zinc oxide (ZnO), and ZnO-Urtica diocia (ZnO-U. diocia) nanoparticles (NPs) and evaluating their antimicrobial effects against S. aureus isolates from diabetic ulcers[1]. The researchers identified several key components in the U. diocia aqueous extract, such as linalool, 4-thujanol, camphor, carvacrol, propanedioic acid, and di(butyl) phthalate, which contribute to the antimicrobial properties of the synthesized nanoparticles. The study revealed that more than 95% of clinical S. aureus isolates were resistant to several antibiotics, including erythromycin, cefoxitin, clindamycin, and ciprofloxacin. This high level of resistance underscores the urgent need for alternative treatment options. The antibacterial effect of the synthesized nanoparticles was assessed using the microdilution method. The results were promising, with the lowest minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) detected at 0.128 g/mL and 0.178 g/mL, respectively. This indicates that the nanoparticles were effective at very low concentrations, highlighting their potent antimicrobial activity. Moreover, the study reported a significant decrease of 90% in the expression rates of virulence genes lukED and RNAIII in S. aureus isolates treated with the nanoparticles. These genes are critical for the pathogenicity of S. aureus, and their downregulation suggests that the nanoparticles not only inhibit bacterial growth but also reduce the bacteria's ability to cause disease. This research is particularly relevant in light of previous findings that emphasize the complexity and severity of DFIs. For instance, DFIs are often polymicrobial, involving a mix of Gram-positive and Gram-negative bacteria, with S. aureus playing a dominant role[3]. The increasing prevalence of MRSA in DFIs has been associated with higher rates of treatment failure, morbidity, and hospitalization costs[3]. The study by the Islamic Azad University researchers provides a potential solution to this problem by introducing nanoparticles that effectively target these resistant strains. Furthermore, the study aligns with the need for a multidisciplinary approach to treating diabetic foot ulcers (DFUs), as highlighted in earlier research[4]. Traditional treatments for DFUs include dressings, topical antibacterial treatments, medications, and debridement techniques. However, the rise of antibiotic-resistant pathogens necessitates the exploration of novel treatments, such as the use of nanoparticles[4]. In conclusion, the study conducted by the Islamic Azad University, Falavarjan Branch, demonstrates the potential of chitosan, ZnO, and ZnO-U. diocia nanoparticles as effective antimicrobial agents against S. aureus in diabetic ulcers. These nanoparticles not only inhibit bacterial growth but also reduce the expression of critical virulence genes, offering a promising alternative to conventional antibiotic treatments. Given the increasing resistance of bacteria and the limitations of current antimicrobial therapies, this innovative approach could significantly improve the management of DFIs and reduce the associated morbidity and mortality.

MedicineHealthBiochem

References

Main Study

1) Assessment of Antimicrobial Activity of Chitosan, ZnO, and Urtica dioica-ZnO NPs Against Staphylococcus aureus Isolated from Diabetic Ulcers.

Published 3rd August, 2024

https://doi.org/10.1007/s00284-024-03633-9

Related Studies

2) Microbiology and Antimicrobial Therapy for Diabetic Foot Infections.

https://doi.org/10.3947/ic.2018.50.1.11

3) Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infection in India: A Growing Menace.

https://doi.org/10.1177/1534734619853668

4) An Overview of Diabetic Foot Ulcers and Associated Problems with Special Emphasis on Treatments with Antimicrobials.

https://doi.org/10.3390/life12071054


Related Articles

An unhandled error has occurred. Reload 🗙